The head of a top Brazilian health research institute says its scientists have discovered the Zika virus in urine and saliva.» Read More
KaloBios Pharmaceuticals, which fired chief executive Martin Shkreli earlier this month, filed for Chapter 11 bankruptcy on Tuesday.
CVS, Chevron, and J&J are among Michael Farr's top 10 stock picks for 2016. Here's why those and seven others made the list.
Two years after the outbreak began, Guinea has been declared free of the Ebola virus, the World Health Organization said Tuesday.
FitBit shares jumped Monday on a report that the wearable fitness device maker's app scored the No. 1 spot in the App Store for free apps.
Many Republican governors support expanding coverage through the ACA, a law that members of Congress from their party want to see fail. NYT reports.
Many Obamacare customers pay more than 10 percent of their incomes toward coverage costs, a report found.
About 2.1 million people under age 35 have signed up for coverage on HealthCare.gov.
Martin Shkreli said prosecutors targeted him because of a drug price hike and Internet antics.
The latest drug-price increases are just the tip of the iceberg, explains former Medtronic CEO Bill George.
As the trading year wraps up, "Fast Money" traders chose the stocks they feel are primed for success in 2016.
Martin Shkreli was suspected of faking a takeover bid for SeraCare — suspicions that were made known to federal authorities back in 2012, according to a source.
About 2.4 million new Obamacare customers have been signed up on the federal insurance exchange.
The resignation comes amid a probe related to his former hedge fund and a drug company he previously headed.
Only 7 percent of the uninsured know that Jan. 31 is the deadline for enrolling in health coverage, according to a survey.
Cancer is mostly a result of external, environmental risk factors rather than down to "bad luck," according to a new study.
Enrollment ends Jan. 31, but people will need to sign up sooner for coverage to be effective Jan. 1.
A committee will hold a hearing on drug pricing soon and also wants details of Valeant's own inquiry into its relationship with a specialty pharmacy.
Canadian drugmaker Valeant Pharmaceuticals cut its revenue and profit forecasts for 2015.
Valeant Pharmaceuticals has struck a deal to distribute some of its medicines at a discount through Walgreens pharmacies.
Before testing your own genome, it helps to realize it can raise more questions than it answers.
Get the best of CNBC in your inbox